Study Identifies USP13 Role in Helping Liver Cancer Cells Survive Low-Oxygen Conditions

A recent study has identified a molecular mechanism that enables hepatocellular carcinoma (HCC) cells to survive and evade immune detection in low-oxygen environments. Researchers, including Hu, Li, and Chen, found that hypoxic conditions within the tumor microenvironment increase the activity of USP13, a protein that plays a critical role in supporting cancer cell survival. The findings provide new insights into how liver cancer adapts to oxygen-deprived conditions.

The study highlights how hypoxia—a common characteristic of solid tumors—triggers an upregulation of USP13. This protein appears to assist HCC cells by stabilizing key molecules involved in cellular survival pathways and immune evasion. The researchers conducted extensive analyses to uncover this pathway, revealing its potential significance in the progression of liver cancer. These findings contribute to the broader understanding of how tumors adapt to hostile environments and resist therapeutic interventions.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 2, 2025

Related posts:

AstraZeneca CEO Pascal Soriot Addresses 10% Year-to-Date Stock Rise Amid Cancer Therapy Developments Origin Pharma Packaging Announces Final Order and Dispatch Dates for 2024 Holiday Season Study Explores Dietary Changes as Potential Therapy for Glioblastoma Patients with One to Two Year Survival Rates AbbVie Raises 2025 Profit Forecast Amid Growing Demand for Skyrizi and Rinvoq

Author

GOAI